Amalgamated Bank Rigel Pharmaceuticals Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.12 - $1.57 $18,777 - $26,322	-16,766 Reduced 74.04%	5,880 $9,000
Q4 2023 Feb 06, 2024	SELL	$0.72 - $1.56 $1,260 - $2,730	-1,750 Reduced 7.17%	22,646 $33,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.82 $514 - $835	459 Added 1.92%	24,396 $31,000
Q1 2023 May 02, 2023	SELL	$1.25 - $2.0 $4,525 - $7,240	-3,620 Reduced 13.14%	23,937 $32,000
Q3 2022 Nov 09, 2022	BUY	$1.1 - $12.2 $485 - $5,380	441 Added 1.63%	27,557 $33,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $469 - $2,233	-700 Reduced 2.52%	27,116 $31,000
Q1 2022 Jun 30, 2022	SELL	$2.22 - $3.45 $5,214 - $8,104	-2,349 Reduced 7.79%	27,816 $83,000
Q4 2021 Feb 15, 2022	SELL	$2.36 - $3.57 $1,045 - $1,581	-443 Reduced 1.45%	30,165 $80,000
Q3 2021 Oct 29, 2021	SELL	$3.5 - $4.5 $5,799 - $7,456	-1,657 Reduced 5.14%	30,608 $111,000
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $18,234 - $26,790	5,901 Added 22.38%	32,265 $140,000
Q4 2020 Feb 12, 2021	BUY	$2.35 - $3.74 $209 - $332	89 Added 0.34%	26,364 $92,000
Q3 2020 Oct 30, 2020	SELL	$1.78 - $4.13 $1,073 - $2,490	-603 Reduced 2.24%	26,275 $63,000
Q2 2020 Aug 10, 2020	SELL	$1.41 - $2.05 $3,801 - $5,526	-2,696 Reduced 9.12%	26,878 $49,000
Q1 2020 May 13, 2020	SELL	$1.27 - $3.0 $168 - $399	-133 Reduced 0.45%	29,574 $46,000
Q4 2019 Feb 13, 2020	BUY	$1.6 - $2.43 $382 - $580	239 Added 0.81%	29,707 $64,000
Q3 2019 Nov 13, 2019	SELL	$1.63 - $2.62 $400 - $644	-246 Reduced 0.83%	29,468 $55,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $8,368 - $10,813	4,143 Added 16.2%	29,714 $78,000
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $1,758 - $2,329	879 Added 3.56%	25,571 $66,000
Q4 2018 Feb 15, 2019	BUY	$2.08 - $3.36 $28,876 - $46,646	13,883 Added 128.44%	24,692 $57,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $36,350 - $50,191	-13,981 Reduced 56.4%	10,809 $35,000
Q2 2018 Jul 18, 2018	BUY	$2.83 - $4.11 $14,520 - $21,088	5,131 Added 26.1%	24,790 $70,000
Q1 2018 May 22, 2018	SELL	$3.54 - $4.54 $1,554 - $1,993	-439 Reduced 2.18%	19,659 $70,000
Q4 2017 Feb 13, 2018	BUY	$3.23 - $4.3 $13,142 - $17,496	4,069 Added 25.39%	20,098 $78,000
Q3 2017 Nov 09, 2017	BUY	$2.18 - $2.57 $34,943 - $41,194	16,029	16,029 $41,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account